The tumor-suppressor role of CIB2 was investigated using specific OC cell lines, in which the re-expression of CIB2 led to hindered neoplastic growth, a 50% reduction in cell migration, and a higher response to carboplatin treatment. The gene discussed is CIB2; the disease is neoplasm.